Contraindications to COVID-19 vaccination include: Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine. Known diagnosed allergy to a component of the COVID-19 vaccine (see Appendix C for a list of vaccine components).
• Been receiving active cancer treatment for tumors or cancers of the blood• Received an organ transplant and are taking medicine to suppress the immune system• Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system• Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)• Advanced or untreated HIV infection• Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response
In emergencies, the experts at the FDA can decide that the benefits of a drug justify a shorter process. If so, the FDA can issue an Emergency Use Authorization (EUA). Under an EUA, the FDA maintains its strict standards but makes decisions more quickly than usual.Jun 24, 2021
People with underlying medical conditions can receive a COVID-19 vaccine as long as they have not had an immediate or severe allergic reaction to a COVID-19 vaccine or to any of the ingredients in the vaccine. Learn more about vaccination considerations for people with underlying medical conditions. Vaccination is an important consideration for adults of any age with certain underlying medical conditions because they are at increased risk for severe illness from COVID-19.
The additional $300/week in Federal Pandemic Unemployment Compensation is available to claimants receiving unemployment benefits under the state or federal regular unemployment compensation programs (UCFE, UCX, PEUC, PUA, EB, STC, TRA, DUA, and SEA). The funds are available for any weeks of unemployment beginning after Dec. 26, 2020, and ending on or before March 14, 2021. You don’t need to apply separately to receive this supplemental amount.Jan 11, 2021
Some people may be at higher risk of severe illness. This includes older adults (65 years and older) and people of any age with serious underlying medical conditions. By using strategies that help prevent the spread of COVID-19 in the workplace, you will help protect all employees, including those at higher risk.
The FDA can issue EUA during a public health emergency—like a pandemic—to allow the use of unapproved medical products to diagnose, treat or prevent serious or life-threatening diseases. Prior to issuing EUA, safety and efficacy must be demonstrated and certain FDA criteria must be met; there also must be evidence that strongly suggests that patients have benefited from a treatment or test, and there are no adequate, approved or available alternatives.
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product PAXLOVID for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg)
COVID-19 vaccines are available for everyone ages 5 years and older at no cost. Vaccines were paid for with taxpayer dollars and will be given free of charge to all people living in the United States, regardless of insurance or immigration status.
Unless one has a vanishingly rare allergy to vaccine adjuvants, those with rheumatic and other autoimmune diseases should have no qualms about COVID-19 vaccination, says Dr. V. Michael Holers, head of the Division of Rheumatology at the University of Colorado School of Medicine.Jul 8, 2021
Researchers have reported higher rates of severe COVID-19 and death in people with autoimmune disease than in the general population. It is unclear whether this is attributable to the autoimmune disease, the immunosuppressive medications taken to treat it, or both.Aug 27, 2021
If you have had a severe allergic reaction to any ingredient in the Pfizer-BioNTech COVID-19 vaccine (such as polyethylene glycol), you should not get this vaccine. If you had a severe allergic reaction after getting a dose of the Pfizer-BioNTech COVID-19 vaccine, you should not get another dose of an mRNA vaccine.